Wayne Laslie brings more than 30 years of experience in the pharmaceutical industry, serving in positions of clinical development, business development, U.S. and international commercial development, marketing, sales, and chief operating officer. He has had responsibility for the commercialization and product introductions of numerous products in the U.S. and abroad. Wayne has held positions of increasing responsibility at Pfizer, predecessor companies of Sanofi-Aventis, Otsuka, Myriad Genetics, and Myrexis. He is the former President and CEO of Zocere, Inc., a biotechnology company engaged in the research and development of stroke therapies. He is now on the board of Zocere and T-NeuroPharma. He is President of the National Atomic Museum Foundation and President of the Board of Trustees of the National Museum of Nuclear Science and History. He also has served on the board of the National Pharmaceutical Council and as a member of the Chancellor’s Advisory Committee at the University of Maryland.